Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Balazs Halmos

Showing results (181-190 of 221) with videos related to

Pageof 23
Sort By:
Neuro-Oncology|April 26, 2015
Does lung cancer mutation status and targeted therapy predict for outcomes and local control in the setting of brain metastases treated with radiation?Tony J C Wang, Shumaila Saad, Yasir H Qureshi, et al.
Science Translational Medicine|January 27, 2012
Mechanisms of acquired crizotinib resistance in ALK-rearranged lung CancersRyohei Katayama, Alice T Shaw, Tahsin M Khan, et al.
Cancer Discovery|May 3, 2020
Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital SystemVikas Mehta, Sanjay Goel, Rafi Kabarriti, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 26, 2016
Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping AlterationsAlexa B Schrock, Garrett M Frampton, James Suh, et al.
Leukemia & Lymphoma|May 20, 2022
High seroconversion rates amongst black and Hispanics with hematologic malignancies after SARS-CoV-2 vaccinationLauren C Shapiro, Astha Thakkar, Radhika Gali, et al.
The Annals of Thoracic Surgery|November 7, 2025
Clinical Characteristics and Surgical Outcomes of Patients Receiving Perioperative Pembrolizumab in KEYNOTE-671Moishe Liberman, David R Jones, Heather Wakelee, et al.
Cancer|February 28, 2026
Multiomic characterization of small cell lung cancer: Real-world insights into therapeutic opportunitiesSonam Puri, Andrew Elliott, Abdul Rafeh Naqash, et al.
Contemporary Clinical Trials|December 18, 2023
Advancing Inclusive Research (AIR) Site Alliance: Facilitating the inclusion of historically underrepresented people in oncology and ophthalmology clinical researchGregory A Vidal, Patricia Chalela, Andrea N Curry, et al.
JTO Clinical and Research Reports|February 16, 2023
Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLCMarina C Garassino, Shirish Gadgeel, Silvia Novello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2009
Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistanceGeorge N Naumov, Monique B Nilsson, Tina Cascone, et al.
Pageof 23

Showing results (181-190 of 221) with videos related to

Sort By:
Pageof 23
Neuro-Oncology|April 26, 2015
Does lung cancer mutation status and targeted therapy predict for outcomes and local control in the setting of brain metastases treated with radiation?Tony J C Wang, Shumaila Saad, Yasir H Qureshi, et al.
Science Translational Medicine|January 27, 2012
Mechanisms of acquired crizotinib resistance in ALK-rearranged lung CancersRyohei Katayama, Alice T Shaw, Tahsin M Khan, et al.
Cancer Discovery|May 3, 2020
Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital SystemVikas Mehta, Sanjay Goel, Rafi Kabarriti, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 26, 2016
Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping AlterationsAlexa B Schrock, Garrett M Frampton, James Suh, et al.
Leukemia & Lymphoma|May 20, 2022
High seroconversion rates amongst black and Hispanics with hematologic malignancies after SARS-CoV-2 vaccinationLauren C Shapiro, Astha Thakkar, Radhika Gali, et al.
The Annals of Thoracic Surgery|November 7, 2025
Clinical Characteristics and Surgical Outcomes of Patients Receiving Perioperative Pembrolizumab in KEYNOTE-671Moishe Liberman, David R Jones, Heather Wakelee, et al.
Cancer|February 28, 2026
Multiomic characterization of small cell lung cancer: Real-world insights into therapeutic opportunitiesSonam Puri, Andrew Elliott, Abdul Rafeh Naqash, et al.
Contemporary Clinical Trials|December 18, 2023
Advancing Inclusive Research (AIR) Site Alliance: Facilitating the inclusion of historically underrepresented people in oncology and ophthalmology clinical researchGregory A Vidal, Patricia Chalela, Andrea N Curry, et al.
JTO Clinical and Research Reports|February 16, 2023
Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLCMarina C Garassino, Shirish Gadgeel, Silvia Novello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2009
Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistanceGeorge N Naumov, Monique B Nilsson, Tina Cascone, et al.
Pageof 23